A muti-center study suggested that aging, the expression of ApoE ε4, the activation of GSK-3beta in the peripheral circulation, and an increased olfactory score are indicative biomarkers of MCI in DM patients, and they can be used together to achieve a higher diagnostic accuracy [128]. This evidence concerns the gene APOE and diabetes mellitus.